Articles related to SYMPTOM MANAGEMENT

Smartwatch-derived nighttime scratching metrics correlated moderately with disease severity and short-term treatment response in a small pediatric atopic dermatitis cohort.

Patients with primary tricuspid regurgitation had longer survival than those with secondary or lead-associated TR in a 12,899-patient Mayo Clinic retrospective cohort.

Switching Parkinson’s patients to Crexont added more than three hours of daily symptom control in interim Phase 4 data. Here’s how to read an open-label, sponsor-run signal.

A meta-analysis of 285 studies found lifetime psychosis in over half of patients with bipolar disorder and comorbid schizophrenia in 8%, with substantial differences between bipolar I and bipolar II subtypes.

“At the end of the day, it’s vital to avoid overuse of opioids—when the harms would outweigh the benefits—but also to avoid underuse.” – Cary P. Gross, MD, Professor of Medicine at YSM

Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalizations, but there is a signal of harm in terms of thirst distress.